The first forum of health economics in Mexico is carried out here

Please Rate Vote 1 Vote 2 Vote 3 Vote 4 Vote 5

Medical experts in different specialties participated in the opening of the two days of the first Health Economics forum in Mexico organized by Sanofi in this city, in which various aspects will be analyzed of the economic impact of the prevention and treatment of the major diseases that plague Mexicans.
The CEO of Sanofi in Mexico, Bertrand Baron said that it is a company that is ethical, transparent and committed to Mexican society.
"This involves improving the quality of life of people through therapeutic solutions and ensure a balance and positive impact in our environment, with the care of the environment, corporate ethics and values; the responsibility for our products and contribution to social development".
He declared that in Sanofi they act "aware of the challenge of the constant changes that the population pyramid imposes on us and that redefine in the medium and long term the health outlook. We respond to this challenge with daily work, strengthening our portfolio, which is the most diverse in the industry, to cover the unmet needs in the Mexican population". And he said that his commitment is to maintain corporate social responsibility and transparency as a practice in our operations: therein lies our sustainability".
SOCIAL RESPONSIBILITY
Our social responsibility, said the manager, starts with a commitment to patient health care, which is what we do best. We seek to understand and meet their needs through greater access to medicines and promoting research of new therapeutic solutions under strict ethical practice, transparency and respect for human rights and the environment.
Furthermore, "as a leading worldwide company, we recognize the impact of our operations and decisions, with the understanding that the sustainability of our audiences is the basis of Sanofi's sustainability".
Friday's schedule included the participation of Francisco Mendoza Rocha, director of corporate affairs at Sanofi with the theme "Sanofi: Health partner in Mexico", Dr. Elsa Sarti, director of epidemiology Latin America Sanofi Pasteur and assistant secretary of the National Academy of Medicine with the theme "epidemiological overview of chronic degenerative diseases in Mexico" and Dr. Armando Arredondo with the theme "economic impact of chronic degenerative diseases in Mexico."
The director said that "our goal of being a diversified company has led to a series of mergers and acquisitions over decades which have consolidated us into our core growth platforms. From 2009-2012 we consolidated the integration of 32 companies with which we show our great capacity for unification".

[readon1 url="http://vallartaopina.net/2013/09/28/realizan-aqui-el-primer-foro-de-economia-de-la-salud-en-mexico"]Source: Vallarta Opina Translated by Rene Tripp[/readon1]